The association was founded in 1978 by 11 professionals who were concerned about the issues that uniquely affect older adults' mental health and well-being. The organization was founded at a time when the percentage of older adults in the United States was growing, which made this organization particularly important. Now, the association has nearly 2,000 members, including psychiatrists and other health care professionals, across the United States, Canada, and abroad.
Past presidents
The following persons have been president of the association:
Public outreach
The Geriatric Mental Health Foundation is a not-for-profit, 5013 organization created by the association to promote awareness of geriatric psychiatry, to reduce mental health stigmas, and to educate the public about mental health issues which disproportionately affect the elderly. Additionally, the foundation focuses on prevention of these late-in-life disorders, and promotes healthy aging practices.
Mental health and medical care of older adults: The association believes that mental health care for older adults is crucial, and should be covered by insurance companies, regardless of where these adults receive their care. They also believe that mental health care for older adults should be integrated into a comprehensive health care system which provides “accessible, affordable, and culturally appropriate” care. Additionally, they believe that advisory boards for managed care providers should include geriatricians and geriatric psychiatrists, to guarantee that the provided coverage appropriately meets the needs of the patients. The association also suggests that healthcare providers receive training on the unique challenges and aspects of geriatric mental health care. Finally, they stress the importance of federal funding and research concerning late-life mental disorders.
Psychologist prescribing privileges: In 2004, the association released a statement that psychologists should not be allowed to prescribe medications. Though the association believes that it is a divisive topic within psychology, they believe that because psychologists have no medical training or authority, they are not qualified to prescribe medications. They believe that allowing psychologists to prescribe medications could prevent patients from receiving collaborative treatment and that it is unnecessary to provide psychologists prescribing powers since psychiatrists and physicians already have that power.
End-of-life care: The association believes that end-of-life care must be respectful of both patient and family wishes, but that care should be consistent with the patient’s desires. End-of-life care should focus on relieving both mental and physical pain, and improving quality of life. The association believes that caregivers should explore all available care and treatment options with the patient, but that patients and authorized surrogates have the right to refuse treatment. The organization believes that if a patient’s ability to make decisions is impaired, decisions should be made by an authorized surrogate.
Additionally, the association believes that patients should be guaranteed continued access to care, regardless of financial status. The organization also stresses the importance of appropriate funding for empirically based research on improving end-of-life care. Finally, the association suggests that all health care professionals receive continual and inclusive training on end-of-life care.
The journal has published the following notable articles:
Localization of Neurofibrillary Tangles and Beta-Amyloid Plaques in the Brains of Living Patients with Alzheimer Disease. Shoghi-Jadid, K., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petric, A., Huang, S., & Barrio, J. R.
Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-analysis of Randomized, Placebo-Controlled Trials. Schneider, L. S., Dagerman, K., & Insel, P. S..
Preserved Cognition in Patients with Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment with Rosiglitazone: A Preliminary Study. Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., Kahn, S. E., Keeling, M. L., & Craft, S..
